Driving innovation in cancer care

Cancer survival rates are at their highest, with more than half of those diagnosed living for at least 10 years. Even with some excellent cancer services in England, more needs to be done to improve cancer care, survival rates and patient experience. The Cancer Vanguard was established to pilot and roll out new models of care that will provide innovative high quality cancer care across the whole patient pathway.

  • The National Cancer Strategy

    The National Cancer Strategy, Achieving World-Class Cancer Outcomes, was published in 2015 and included 96 recommendations to help transform the care that the NHS delivers for all those affected by cancer. The Cancer Vanguard has been tasked with contributing to the delivery of some of the key outcomes of the National Cancer Strategy.

    Find out more about the National Cancer Strategy
  • About us

    The Cancer Vanguard is a partnership led by: The Christie NHS Foundation Trust, The Royal Marsden NHS Foundation Trust, and University College London Hospitals NHS Foundation Trust. It works across a population of 10.7 million people, which provides an unprecedented opportunity to transform and create new models of cancer care that can be reproduced nationally.

    Find out more about the Cancer Vanguard

Latest news from the Cancer Vanguard

Find out more

We use cookies to give you the best possible experience. If you continue, we’ll assume you are happy to receive the cookies we place. Privacy and cookies information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.